Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Transdermal Drug Delivery Systems

Transdermal Drug Delivery Systems

Transdermal drug delivery systems (TDDS) enable the controlled release of drugs across the skin into systemic circulation. They are particularly advantageous for drugs with short half-lives or narrow therapeutic indices, as they maintain consistent plasma concentrations and reduce the risk of subtherapeutic or toxic levels.TDDS are categorized into monolithic, reservoir, and mixed systems. Monolithic systems embed the drug in a polymer matrix, where diffusion governs release. Reservoir systems...

Pharmaceutical Poisoning: Treatment Strategies

Pharmaceutical Poisoning: Treatment Strategies

Treatment strategies for poisoning are a critical aspect of emergency medicine, focusing on preventing the absorption of toxins and enhancing their elimination. When a poisoning incident occurs, the first response is to halt exposure and decontaminate the patient, particularly through gastrointestinal (GI) methods if the poison was ingested.Gastrointestinal Decontamination Techniques:Activated charcoal is the cornerstone of GI decontamination. It works through adsorption, binding the toxin to...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Think This Can't Happen to You?

Clinical journal of oncology nursing·2025

Same author

Introduction.

Seminars in oncology nursing·2018

Same author

A Pathway to Publishing an Oncology Nursing Book.

Seminars in oncology nursing·2018

Same author

Publishing in Oncology Nursing: A Look to the Past, Present, and Future.

Seminars in oncology nursing·2018

Same author

2016 Updated American Society of Clinical Oncology/Oncology Nursing Society Chemotherapy Administration Safety Standards, Including Standards for Pediatric Oncology

Oncology nursing forum·2017

Same author

2016 Updated American Society of Clinical Oncology/Oncology Nursing Society Chemotherapy Administration Safety Standards, Including Standards for Pediatric Oncology.

Journal of oncology practice·2016

Search research articles

Related Experiment Video

Updated: Jul 13, 2026

Chemotherapy-induced Vascular Toxicity - Real-time In vivo Imaging of Vessel Impairment

Chemotherapy-induced Vascular Toxicity - Real-time In vivo Imaging of Vessel Impairment

Published on: January 7, 2015

Totect: a new agent for treating anthracycline extravasation.

Lisa Schulmeister¹

¹LisaSchulmeister@hotamil.com

Clinical Journal of Oncology Nursing

|July 12, 2007

Summary

Totect (dexrazoxane) effectively treats anthracycline extravasation, preventing tissue damage. Clinical trials show only one patient developed necrosis, highlighting its efficacy for chemotherapy side effect management.

Area of Science:

Oncology
Pharmacology
Clinical Medicine

Background:

Anthracycline chemotherapy agents can cause severe tissue damage (extravasation) when they leak into surrounding healthy tissues.
Effective management of anthracycline extravasation is critical to prevent complications such as tissue necrosis.
Existing treatment approaches for extravasation have varying degrees of reported success.

Purpose of the Study:

To evaluate the efficacy of Totect (dexrazoxane for injection) as a treatment for anthracycline extravasation.
To provide data supporting the use of dexrazoxane in managing chemotherapy extravasation injuries.

Main Methods:

Analysis of data from two prospective clinical trials.
Inclusion of patients with biopsy-confirmed extravasations of doxorubicin or epirubicin.

More Related Videos

Computed Tomography (CT) Guided Implantation of a Totally Implantable Venous Access Port (TIVAP) through Subclavian Vein

Computed Tomography (CT) Guided Implantation of a Totally Implantable Venous Access Port (TIVAP) through Subclavian Vein

Published on: January 13, 2026

Intraductal Delivery and X-ray Visualization of Ethanol-Based Ablative Solution for Prevention and Local Treatment of Breast Cancer in Mouse Models

Intraductal Delivery and X-ray Visualization of Ethanol-Based Ablative Solution for Prevention and Local Treatment of Breast Cancer in Mouse Models

Published on: April 1, 2022

Related Experiment Videos

Last Updated: Jul 13, 2026

Chemotherapy-induced Vascular Toxicity - Real-time In vivo Imaging of Vessel Impairment

Chemotherapy-induced Vascular Toxicity - Real-time In vivo Imaging of Vessel Impairment

Published on: January 7, 2015

Computed Tomography (CT) Guided Implantation of a Totally Implantable Venous Access Port (TIVAP) through Subclavian Vein

Computed Tomography (CT) Guided Implantation of a Totally Implantable Venous Access Port (TIVAP) through Subclavian Vein

Published on: January 13, 2026

Intraductal Delivery and X-ray Visualization of Ethanol-Based Ablative Solution for Prevention and Local Treatment of Breast Cancer in Mouse Models

Intraductal Delivery and X-ray Visualization of Ethanol-Based Ablative Solution for Prevention and Local Treatment of Breast Cancer in Mouse Models

Published on: April 1, 2022

Treatment with Totect (dexrazoxane for injection).

Main Results:

A low incidence of tissue necrosis was observed in patients treated with Totect.
Only 1 out of 54 patients (1.85%) with confirmed anthracycline extravasation developed tissue necrosis.
These findings suggest a high efficacy rate for dexrazoxane in preventing severe local tissue injury.

Conclusions:

Totect (dexrazoxane for injection) is an effective treatment for anthracycline extravasation.
The drug significantly reduces the risk of tissue necrosis following extravasation of doxorubicin and epirubicin.
Healthcare professionals, particularly nurses, require education on the administration and benefits of dexrazoxane for managing chemotherapy extravasations.